| __timestamp | TG Therapeutics, Inc. | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 24518692 | 5496000 |
| Thursday, January 1, 2015 | 19886580 | 9786000 |
| Friday, January 1, 2016 | 12631689 | 6792000 |
| Sunday, January 1, 2017 | 21977998 | 7313000 |
| Monday, January 1, 2018 | 20759000 | 8382000 |
| Tuesday, January 1, 2019 | 20838000 | 10803000 |
| Wednesday, January 1, 2020 | 121812000 | 12944000 |
| Friday, January 1, 2021 | 152137000 | 21967000 |
| Saturday, January 1, 2022 | 83231000 | 32810000 |
| Sunday, January 1, 2023 | 122706000 | 46542000 |
Igniting the spark of knowledge
In the competitive landscape of biotechnology, understanding the financial strategies of key players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of TG Therapeutics, Inc. and Xenon Pharmaceuticals Inc. over the past decade. From 2014 to 2023, TG Therapeutics consistently outpaced Xenon in SG&A spending, peaking in 2021 with expenses nearly 10 times higher than their 2014 figures. This surge reflects TG Therapeutics' aggressive market expansion and investment in operational infrastructure. In contrast, Xenon Pharmaceuticals exhibited a more conservative growth trajectory, with a steady increase in SG&A expenses, culminating in a 2023 figure that is approximately 8 times their 2014 expenditure. This data highlights the divergent strategies of these two companies, offering insights into their market positioning and future growth potential.
AbbVie Inc. or TG Therapeutics, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of AstraZeneca PLC and Xenon Pharmaceuticals Inc.
argenx SE or TG Therapeutics, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of BeiGene, Ltd. and Xenon Pharmaceuticals Inc.
Intra-Cellular Therapies, Inc. and TG Therapeutics, Inc.: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Xenon Pharmaceuticals Inc.
Breaking Down SG&A Expenses: Sarepta Therapeutics, Inc. vs TG Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Walgreens Boots Alliance, Inc. or Xenon Pharmaceuticals Inc.
SG&A Efficiency Analysis: Comparing Rhythm Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Breaking Down SG&A Expenses: Perrigo Company plc vs Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc. vs MorphoSys AG: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Xenon Pharmaceuticals Inc. and Agios Pharmaceuticals, Inc.